(Q41122108)

27 September 2017

title

beta-Amyloid-induced IL-1 beta release from an activated human monocyte cell line is calcium- and G-protein-dependent (English)

1 reference

27 September 2017

Lorton D

1

1 reference

27 September 2017

publication date

1 March 1997

1 reference

Mechanisms of Ageing and Development

27 September 2017

published in

1 reference

27 September 2017

volume

94

1 reference

27 September 2017

issue

1-3

1 reference

27 September 2017

page(s)

199-211

1 reference

Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease

27 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2896%2901847-7

7 January 2021

Complement and cytokine gene expression in cultured microglial derived from postmortem human brains

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2896%2901847-7

7 January 2021

beta-Amyloid induces increased release of interleukin-1 beta from lipopolysaccharide-activated human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2896%2901847-7

7 January 2021

The amyloid beta-protein of Alzheimer's disease is chemotactic for mononuclear phagocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2896%2901847-7

7 January 2021

Glial cytokines in Alzheimer's disease: Review and pathogenic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2896%2901847-7

7 January 2021

Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2896%2901847-7

7 January 2021

The molecular biology of leukocyte chemoattractant receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2896%2901847-7

7 January 2021

G-protein activation by interleukin 8 and related cytokines in human neutrophil plasma membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2896%2901847-7

7 January 2021

Establishment and characterization of a human acute monocytic leukemia cell line (THP-1)

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2896%2901847-7

7 January 2021

A commercially available serum-free medium appropriate for studies of macrophage functions in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2896%2901847-7

7 January 2021

β-Amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2896%2901847-7

7 January 2021

Synthetic Alzheimer amyloid beta/A4 peptides enhance production of complement C3 component by cultured microglial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2896%2901847-7

7 January 2021

Activation of macrophages by Alzheimer beta amyloid peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2896%2901847-7

7 January 2021

A 109-amino-acid C-terminal fragment of Alzheimer's-disease amyloid precursor protein contains a sequence, -RHDS-, that promotes cell adhesion

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2896%2901847-7

7 January 2021

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2896%2901847-7

7 January 2021

Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2896%2901847-7

7 January 2021

Immunochemical identification of the serine protease inhibitor alpha 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2896%2901847-7

7 January 2021

Alpha 2-macroglobulin and subacute-phase responses in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2896%2901847-7

7 January 2021

Immunodetection of the amyloid P component in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2896%2901847-7

7 January 2021

Alpha 1-antitrypsin and alpha 1-antichymotrypsin are in the lesions of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2896%2901847-7

7 January 2021

Distribution of the Protease Inhibitor α1-Antichymotrypsin in Cerebral and Systemic Amyloid

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2896%2901847-7

7 January 2021

Clinical trial of indomethacin in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2896%2901847-7

7 January 2021

Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease?: The Rotterdam Study

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2896%2901847-7

7 January 2021

Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2896%2901847-7

7 January 2021

Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2896%2901847-7

7 January 2021

A case-control study of Alzheimer's disease in Australia

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2896%2901847-7

7 January 2021

A case-control study of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2896%2901847-7

7 January 2021

Rheumatoid arthritis and senile dementia of the Alzheimer's type.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2896%2901847-7

7 January 2021

A case-control study of Alzheimer's disease in China

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2896%2901847-7

7 January 2021

Nonsteroidal antiinflammatory drug use in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2896%2901847-7

7 January 2021

Anti‐inflammatory agents as a therapeutic approach to Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2896%2901847-7

7 January 2021

Anti-inflammatory drugs and Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2896%2901847-7

7 January 2021

Alzheimer's disease and rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2896%2901847-7

7 January 2021

Nonsteroidal anti-inflammatory drugs in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2896%2901847-7

7 January 2021

Towards a better aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2896%2901847-7

7 January 2021

ADP-ribosylation of guanyl nucleotide-binding regulatory proteins by bacterial toxins

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2896%2901847-7

7 January 2021

Neuroimmune mechanisms in Alzheimer disease pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2896%2901847-7

7 January 2021

10.1016/S0047-6374(96)01847-7

Identifiers

DOI

1 reference

27 September 2017

1 reference